Javascript must be enabled to continue!
Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
View through CrossRef
Enhancers are a crucial regulator of differential gene expression programs. Enhancers are the cis-regulatory sequences determining target genes’ spatiotemporal and quantitative expression. Here, we show that Kaposi’s sarcoma-associated herpesvirus (KSHV) terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters. The KSHV enhancer is occupied by latency-associated nuclear antigen (LANA) and its interacting proteins, such as CHD4. Neighboring terminal repeat (TR) fragments to lytic gene promoters drastically enhanced KSHV replication and transcription activator and LANA transcription regulatory functions. This study, thus, proposes a new latency–lytic switch model in which TR accessibility to the KSHV gene promoters regulates viral inducible gene expression.
American Society for Microbiology
Title: Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
Description:
Enhancers are a crucial regulator of differential gene expression programs.
Enhancers are the cis-regulatory sequences determining target genes’ spatiotemporal and quantitative expression.
Here, we show that Kaposi’s sarcoma-associated herpesvirus (KSHV) terminal repeats fulfill the enhancer definition for KSHV inducible gene promoters.
The KSHV enhancer is occupied by latency-associated nuclear antigen (LANA) and its interacting proteins, such as CHD4.
Neighboring terminal repeat (TR) fragments to lytic gene promoters drastically enhanced KSHV replication and transcription activator and LANA transcription regulatory functions.
This study, thus, proposes a new latency–lytic switch model in which TR accessibility to the KSHV gene promoters regulates viral inducible gene expression.
Related Results
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
KSHV Terminal Repeat Regulates Inducible Lytic Gene Promoters
KSHV Terminal Repeat Regulates Inducible Lytic Gene Promoters
Summary
The Kaposi’s sarcoma-associated herpesvirus (KSHV) genome consists of an approximately 140 kb unique coding region flanked by multiple copies of 0.8 kb term...
KSHV genome harbors both constitutive and lytically induced enhancers
KSHV genome harbors both constitutive and lytically induced enhancers
Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) belongs to the gamma-herpesvirus family and is a well-known human oncogenic virus. In infected cells, the vi...
Studies on Gene Enhancer with KSHV mini-chromatin
Studies on Gene Enhancer with KSHV mini-chromatin
Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) genome contains a terminal repeats (TR) sequence. Previous studies demonstrated that KSHV...
METTL16 controls Kaposi’s sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle
METTL16 controls Kaposi’s sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle
AbstractOncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases, both of which are important for the development of KSHV-related ca...
METTL16 Controls Kaposi’s Sarcoma-Associated Herpesvirus Replication by Regulating
S
-Adenosylmethionine Cycle
METTL16 Controls Kaposi’s Sarcoma-Associated Herpesvirus Replication by Regulating
S
-Adenosylmethionine Cycle
Abstract
Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) consists of latent and lytic replication phases, both of which are important fo...
Oral Kaposi’s sarcoma in immunosuppressed patients – report of cases
Oral Kaposi’s sarcoma in immunosuppressed patients – report of cases
Kaposi sarcoma is a vascular neoplasm composed of endothelium-lined vascular spaces and spindle-shaped cells. It often manifests with multiple vascular nodules on the skin and othe...
Kaposi sarcoma-associated herpesvirus infection in HIV patients: potential role of HIV-associated extracellular vesicles
Kaposi sarcoma-associated herpesvirus infection in HIV patients: potential role of HIV-associated extracellular vesicles
Abstract
Kaposi sarcoma-associated herpesvirus (KSHV) is the causal agent for Kaposi sarcoma (KS), the most common malignancy in people living with HIV/AIDS. The or...

